Multivariate data analysis using D-optimal designs, partial least squares,and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitors
E. Giraud et al., Multivariate data analysis using D-optimal designs, partial least squares,and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitors, J MED CHEM, 43(9), 2000, pp. 1807-1816
We have investigated the combined use of partial least squares (PLS) and st
atistical design principles in principal property space (PP-space), derived
from principal component analysis (PCA), to analyze farnesyltransferase in
hibitors in order to identify "activity trends" (an approach we call a "dir
ectional" approach) and quantitative structure-activity relationships (QSAR
) for a congeneric series of inhibitors: the benzo[f]perhydroisoindole (BPH
I) series. Trends observed in the PCA showed that the descriptors used were
relevant to describe our structural data set by clearly identifying two we
ll-defined structural subclasses of inhibitors. D-Optimal design techniques
allowed us to define a training set for PLS study in PP-space. Models were
derived for each biological assay under evaluation: the in vitro Ki-Ras an
d cellular HCT116 tests. Each of these assay-based sets was subdivided once
more into two subsets according to two structural classes in this BPHI ser
ies as revealed by the PCA model. The response surface modeling (RSM) metho
dology was used for each subset, and the corresponding RSM plots helped us
identify "activity trends" exploited to guide further analogue design. For
more precise activity predictions more refined PLS models on constrained PP
-spaces were developed for each subset. This approach was validated with pr
edicted sets and demonstrates that useful information can be extracted from
just a few very informative and representative compounds. Finally, we also
showed the potential use of such a strategy at an early stage of an optimi
zation process to extract the first "activity trends" that might support de
cision making and guide medicinal chemists in the initial design of new ana
logues and/or lead followup libraries.